A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
In vivoimaging of neuromelanin in Parkinson's disease using18F-AV-1451 PET
2016
Brain
PET may be the first radiotracer to reflect the loss of pigmented neurons in the substantia nigra of parkinsonian patients. The magnitude of the nigral signal loss was smaller than the decrease in striatal dopamine transporter signal measured by dopamine transporter SPECT. These findings suggest a more severe loss of striatal nerve terminal function compared with neuronal cell bodies, in accordance with the post-mortem literature.
doi:10.1093/brain/aww098
pmid:27190023
fatcat:pwevgxy5cngvnjleepo46w3rkq